These polymer-based strategies of miRNA-34a delivery might represent novel therapeutic challenges with highly selective tumor cell death and tumor growth inhibition in CD44-positive tumors, thus opening a therapeutic window for autophagy inhibition for cancer treatment. Here, CD44 is linked to neoplasm.